Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 11 X users

patent: 2 patents

Citations

dimensions_citation: 73 Dimensions

Readers on

mendeley: 62 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

ENHANCEMENT OF CD47 BLOCKADE THERAPY WITH ANTI-VEGF AGENTS

Application WO-2023079438-A1

World Intellectual Property Organisation (WIPO)

COMBINATION OF ANTI-DC47 ANTIBODY AND ANTI-VEGF ANTIBODY AND USE THEREOF

Application WO-2021170077-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.